The process for developing new drugs is incredibly complex, requiring the evaluation of hundreds of thousands of candidate compounds before a project reaches the clinical trial stage. This process is slow, costly, and requires immense…
Microsoft Research Senior Researcher Mehdi Fatemi, MIT Assistant Professor Marzyeh Ghassemi, and PhD student Taylor W. Killian answer several questions about their NeurIPS 2021 paper, “Medical Dead-ends and Learning to Identify High-risk States and Treatments.”…
As the pandemic overburdens medical facilities and clinicians become increasingly overworked, the ability to make quick decisions on providing the best possible treatment is even more critical. In urgent health situations, such decisions can mean…
